Seeking Alpha

Cardiovascular Systems (CSII +0.4%) says it's enrolled the first patient in Liberty 360 study, a...

Cardiovascular Systems (CSII +0.4%) says it's enrolled the first patient in Liberty 360 study, a post-market evaluation of the acute and long-term clinical and economic effectiveness of its orbital atherectomy system in treating peripheral arterial disease. The study is unique in that it evaluates success based on long-term outcomes and durability, rather than acute angiographic results of the various treatments.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|